Co-expression of POU5F1/OCT4 and NANOG promotes malignancy and EMT in LUAD [39], whereas reduced E-cadherin is associated with poor prognosis and metastasis in NSCLC patients [41, 42]. The gene discussed is POU5F1; the disease is non-small cell lung carcinoma.